How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Areas of Interest at Shionogi & Co.

Organization name

Shionogi & Co., Ltd. business development


Shionogi & Co., Ltd. conducts its research and development program based on its policy of continually providing the superior medicines essential to people´s health. This commitment has allowed them to continually develop innovative medicines with excellent safety and efficacy profiles and to deliver high-quality products to many people suffering from illness.

They will spare no effort in carrying out challenging and speedy research and development to fulfill their mission of delivering pharmaceuticals that offer an even higher level of satisfaction to patients` their families and healthcare providers and improve the quality of life for patients and their families.

In addition to the three targeted areas of infections` pain and metabolic syndrome` Shionogi is also focusing on disease areas such as allergies` respiratory illnesses` cancer and central nervous system disorders that will add challenging frontier research for future advances. With this approach` Shionogi will maintain a steadily flowing product pipeline centered on internally developed products` and plans to move at least five new items to Phase âÂ…¡ or higher by the end of the second medium-term management plan in March 2010.

Shionogi´s research laboratories aggressively apply cutting-edge scientific technologies such as ultra-high-throughput screening and genomic drug discovery to facilitate the efficient development of innovative pharmaceuticals.

In addition` Shionogi actively collaborates with external research institutions to strengthen basic technologies for drug discovery and drug discovery target searches.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries